Genetic Signatures Ltd (GSS) - Total Liabilities

Latest as of December 2025: AU$4.95 Million AUD ≈ $3.50 Million USD

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has total liabilities worth AU$4.95 Million AUD (≈ $3.50 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Genetic Signatures Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Genetic Signatures Ltd to evaluate short-term liquidity relative to the company's equity base.

Genetic Signatures Ltd Competitors by Total Liabilities

The table below lists competitors of Genetic Signatures Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
SeaStar Medical Holding Corporation NASDAQ:ICU	USA	$3.74 Million
Jenn Feng New Energy Co Ltd TW:1538	Taiwan	NT$131.82 Million
Aterian Inc NASDAQ:ATER	USA	$14.35 Million
Victoria Insurance Tbk PT JK:VINS	Indonesia	Rp62.26 Billion
Chemomab Therapeutics Ltd DRC NASDAQ:CMMB	USA	$1.48 Million
Noble Helium Ltd AU:NHE	Australia	AU$11.07 Million
New Era Helium Inc Common Stock NASDAQ:NEHC	USA	$10.49 Million
Inocycle Technology Tbk PT JK:INOV	Indonesia	Rp682.16 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Genetic Signatures Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Genetic Signatures Ltd (GSS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.99	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	3.60	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genetic Signatures Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genetic Signatures Ltd (2013–2025)

The table below shows the annual total liabilities of Genetic Signatures Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$4.54 Million ≈ $3.21 Million	-26.62%
2024-06-30	AU$6.18 Million ≈ $4.38 Million	+0.32%
2023-06-30	AU$6.16 Million ≈ $4.36 Million	+27.04%
2022-06-30	AU$4.85 Million ≈ $3.43 Million	+3.08%
2021-06-30	AU$4.71 Million ≈ $3.33 Million	+24.33%
2020-06-30	AU$3.79 Million ≈ $2.68 Million	+142.54%
2019-06-30	AU$1.56 Million ≈ $1.10 Million	+29.07%
2018-06-30	AU$1.21 Million ≈ $855.77K	+1.65%
2017-06-30	AU$1.19 Million ≈ $841.86K	-7.30%
2016-06-30	AU$1.28 Million ≈ $908.13K	+72.71%
2015-06-30	AU$743.14K ≈ $525.82K	+100.59%
2014-06-30	AU$370.48K ≈ $262.13K	-91.24%
2013-06-30	AU$4.23 Million ≈ $2.99 Million	--

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$11.89 Million

AU$16.81 Million AUD

Market Cap Rank

#26615 Global

#1258 in Australia

Share Price

AU$0.07

Change (1 day)

+4.23%

52-Week Range

AU$0.07 - AU$0.43

All Time High

AU$2.75